PuraPharm Corporation Limited

HKEX:1498.HK

0.66 (HKD) • At close November 8, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Omzet 207.627211.778195.081217.309230.76356.835302.757321.383280.432362.321333.558358.899386.604328.473263.093323.737212.249286.998186.902210.746155.60691.588
Kosten van de omzet 94.365107.67184.342105.92681.557130.579107.162116.899116.227157.176141.113140.31150.293113.48382.225116.54170.641100.26667.90277.07657.16533.56
Brutowinst 113.262104.107110.739111.383149.203226.256195.595204.484164.205205.145192.445218.589236.311214.99180.868207.196141.608186.732119133.6798.44158.028
Brutowinstmarge 0.5460.4920.5680.5130.6470.6340.6460.6360.5860.5660.5770.6090.6110.6550.6870.640.6670.6510.6370.6340.6330.634
Onderzoek- en ontwikkelingskosten 5.5976.5488.43912.1428.06312.83311.11713.3637.41522.62910.85517.3529.01510.2019.0839.9028.2138.5147.0898.8177.3160
Algemene en administratieve kosten 75.70890.580.60777.7180.00685.85782.28677.28975.677118.913105.70775.39399.21287.41485.7964.57866.27144.17861.91935.6937.07220.257
Verkoop- en marketingkosten 40.20441.48550.17375.02582.358127.56292.444113.76196.778110.356115.856114.016115.979111.14780.60688.88465.49682.22957.98552.18746.98924.794
Verkoop-, algemene en administratieve kosten 114.648127.934121.201153.542151.339214.258166.025184.644168.145212.955212.397231.83215.191232.344166.396176.614131.767139.686119.90496.14384.06145.051
Overige kosten 0-2.30700000000000000000-1.427-0.968-0.968
Bedrijfskosten 120.245136.789129.64165.684159.402227.091177.142198.007175.56235.584223.252197.166209.755208.807160.303174.457127.059137.614118.57493.27684.15544.083
Bedrijfsresultaat -6.983-32.682-18.901-54.301-10.199-0.83518.4536.477-11.355-30.439-30.807-11.87521.12-17.35414.47230.5829.84147.046-0.90437.52714.3813.838
Bedrijfsresultaat ratio -0.034-0.154-0.097-0.25-0.044-0.0020.0610.02-0.04-0.084-0.092-0.0330.055-0.0530.0550.0940.0460.164-0.0050.1780.0920.151
Totaal overige inkomsten en kosten netto -7.782-33.116-17.613-30.182-24.5-133.743-1.06717.35227.743-142.963-11.94122.714-5.42813.898-0.685-2.3010.545-1.671-4.337-3.32-6.257-3.255
Inkomen voor belasting -14.765-65.798-36.514-84.483-34.699-134.57817.38623.82916.388-173.402-42.74810.83915.692-3.45613.78728.28110.38645.375-5.24134.2078.12310.583
Inkomen voor belasting ratio -0.071-0.311-0.187-0.389-0.15-0.3770.0570.0740.058-0.479-0.1280.030.041-0.0110.0520.0870.0490.158-0.0280.1620.0520.116
Belastingkosten 3.9212.6081.161-4.1725.204-0.7275.4123.5564.9518.6762.4323.3812.3443.7934.6494.4042.1019.3212.3556.21.6231.956
Nettowinst -18.686-68.406-37.675-80.311-39.903-133.85111.97420.27311.437-182.078-45.187.45813.348-7.2499.13823.8778.28536.054-7.59627.9876.4768.627
Nettowinstmarge -0.09-0.323-0.193-0.37-0.173-0.3750.040.0630.041-0.503-0.1350.0210.035-0.0220.0350.0740.0390.126-0.0410.1330.0420.094
WPA (Winst Per Aandeel) -0.047-0.17-0.095-0.2-0.1-0.340.030.0520.033-0.66-0.170.030.054-0.030.040.110.0370.16-0.0450.1313.2317.62
Verwaterde WPA -0.047-0.17-0.095-0.2-0.1-0.340.030.0520.033-0.66-0.170.030.054-0.0290.040.110.0370.16-0.0450.1313.2317.62
EBITDA 4.437-5.4752.483-33.94818.10921.05446.70329.11113.6374.7550.7548.61136.228-3.17925.07537.90317.79752.5076.63544.08521.14117.234
EBITDA ratio 0.021-0.0260.013-0.1560.0780.0590.1540.0910.0490.0130.0020.0240.094-0.010.0950.1170.0840.1830.0350.2090.1360.188